Technical Analysis for EPGNY - Epigenomics Ag

Grade Last Price % Change Price Change
grade F 9.26 0.11% 0.0100
EPGNY closed up 0.11 percent on Thursday, August 22, 2019, on 13 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Down Down
See historical EPGNY trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
Pocket Pivot Bullish Swing Setup 0.11%
Narrow Range Bar Range Contraction 0.11%
Wide Bands Range Expansion 0.11%
Gapped Up Strength 0.11%
Oversold Stochastic Weakness 0.11%
New 52 Week Closing Low Bearish 3.35%

Older signals for EPGNY ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Epigenomics is a molecular diagnostics company focused on blood-based detection of cancers using its proprietary DNA methylation biomarker technology. The company develops and commercializes diagnostic products across multiple cancer indications with high medical need. Epigenomics' lead product, Epi proColon, is a blood-based screening test for the detection of colorectal cancer. Epi proColon has received approval from the U.S. Food and Drug Administration (FDA) and is currently marketed in the United States, Europe, and China and selected other countries. Epigenomics’ second product, Epi proLung, is in development as a blood-based test for lung cancer detection. For more information, visit www.epigenomics.com.
Medicine Biotechnology RTT Branches Of Biology Cancer Clinical Medicine Cancers Biomarkers Colorectal Cancer Diagnostic Products Lung Cancer Medical Genetics Molecular Diagnostics Cancer Detection U.S. Food And Drug Administration Epigenomics Ag
Is EPGNY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 41.74
52 Week Low 8.96
Average Volume 773
200-Day Moving Average 0.0
50-Day Moving Average 19.7522
20-Day Moving Average 11.4795
10-Day Moving Average 10.12
Average True Range 1.1987
ADX 25.48
+DI 33.8602
-DI 52.8946
Chandelier Exit (Long, 3 ATRs ) 12.4239
Chandelier Exit (Short, 3 ATRs ) 12.556100000000001
Upper Bollinger Band 14.7877
Lower Bollinger Band 8.1713
Percent B (%b) 0.16
BandWidth 57.636657
MACD Line -2.6988
MACD Signal Line -3.0034
MACD Histogram 0.3046
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.2600
Resistance 3 (R3) 9.2600 9.2600 9.2600
Resistance 2 (R2) 9.2600 9.2600 9.2600 9.2600
Resistance 1 (R1) 9.2600 9.2600 9.2600 9.2600 9.2600
Pivot Point 9.2600 9.2600 9.2600 9.2600 9.2600
Support 1 (S1) 9.2600 9.2600 9.2600 9.2600 9.2600
Support 2 (S2) 9.2600 9.2600 9.2600 9.2600
Support 3 (S3) 9.2600 9.2600 9.2600
Support 4 (S4) 9.2600